GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Novartis targets 5% annual sales growth through 2031 - Finance news and analysis from Global Banking & Finance Review
Finance

Novartis targets 5% annual sales growth through 2031

Published by Global Banking & Finance Review

Posted on November 19, 2026

1 min read

· Last updated: November 19, 2026

Add as preferred source on Google

Novartis Sets 5% Annual Sales Growth Target Through 2031 at London Event

Novartis Outlines Updated Mid-Term Sales Targets

New Sales Growth Projections Announced

Details of the Updated Forecast

LONDON, Nov 19 (Reuters) - Swiss drugmaker Novartis on Thursday outlined new mid-term sales targets that were at the lower end of the range it had given a year earlier, ahead of its annual investor event in London. Novartis now expects net sales to grow 5% annually at constant currencies from 2026 through 2031. Previously, the company expected sales growth of 5%-6% through 2030.

Reporting and Editorial Credits

(Reporting by Bhanvi Satija and Marleen KaesebierEditing by Dave Graham)

Key Takeaways

  • New guidance reflects slightly more conservative outlook: 5% CAGR from 2026–2031 versus previous 5–6% through 2030, introduced at the London investor event.
  • The adjustment likely responds to patent expirations and pipeline dynamics, though Novartis remains supported by strong performance of key brands and its robust R&D pipeline (novartis.com).
  • The updated projection was unveiled at Novartis’ “Meet Novartis Management 2026” investor event in London on November 19, 2026, which also featured discussions on AI in R&D and sustainability progress (novartis.com)

References

Frequently Asked Questions

What is Novartis's new annual sales growth target?
Novartis targets 5% annual sales growth at constant currencies from 2026 through 2031.
When did Novartis announce the revised sales targets?
Novartis announced the new sales targets ahead of its annual investor event in London on Thursday.
What currencies does Novartis use for its sales growth estimates?
Novartis bases its sales growth estimates on constant currencies.

Tags

Related Articles

More from Finance

Explore more articles in the Finance category